{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:36:48Z","timestamp":1772761008911,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,19]],"date-time":"2013-05-19T00:00:00Z","timestamp":1368921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s15010-013-0477-0","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T05:01:00Z","timestamp":1368853260000},"page":"769-774","source":"Crossref","is-referenced-by-count":22,"title":["Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone"],"prefix":"10.1007","volume":"41","author":[{"given":"S. A.","family":"Winans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Luce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hasbun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,19]]},"reference":[{"key":"477_CR1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373\u201383.","journal-title":"J Chron Dis"},{"key":"477_CR2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1532-5415.2007.01133.x","volume":"55","author":"AM Cox","year":"2007","unstructured":"Cox AM, Malani PN, Wiseman SW, Kauffman CA. Home intravenous antimicrobial infusion therapy: a viable option in older adults. J Am Geriatr Soc. 2007;55:645\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"477_CR3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","volume":"96","author":"DT Durack","year":"1994","unstructured":"Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200\u20139.","journal-title":"Am J Med"},{"key":"477_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/313620","volume":"30","author":"BJ Guglielmo","year":"2000","unstructured":"Guglielmo BJ, Luber AD, Paletta D Jr, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis. 2000;30:205\u20137.","journal-title":"Clin Infect Dis"},{"key":"477_CR5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med"},{"key":"477_CR6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/379021","volume":"37","author":"EC Nannini","year":"2003","unstructured":"Nannini EC, Singh KV, Murray BE. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis. 2003;37:1194\u20138.","journal-title":"Clin Infect Dis"},{"key":"477_CR7","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","volume":"53","author":"EC Nannini","year":"2009","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, Fowler VG Jr, Murray BE. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother. 2009;53:3437\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"477_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2011.11.005","volume":"39","author":"SC Nicholson","year":"2012","unstructured":"Nicholson SC, Welte T, File TM Jr, Strauss RS, Michiels B, Kaul P, Balis D, Arbit D, Amsler K, Noel GJ. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation. Int J Antimicrob Agents. 2012;39:240\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"477_CR9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","volume":"17","author":"M Paul","year":"2010","unstructured":"Paul M, Zemer-Wassercug N, Talker O, Lishtzinsky Y, Lev B, Samra Z, Leibovici L, Bishara J. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect. 2010;17:1581\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"477_CR10","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1093\/infdis\/128.Supplement_2.S386","volume":"128","author":"EL Quinn","year":"1973","unstructured":"Quinn EL, Pohlod D, Madhavan T, Burch K, Fisher E, Cox F. Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. J Infect Dis. 1973;128:S386\u201391.","journal-title":"J Infect Dis"},{"key":"477_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.4.5733.455","volume":"4","author":"R Sutherland","year":"1970","unstructured":"Sutherland R, Croydon EA, Rolinson GN. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. Br Med J. 1970;4:455\u201360.","journal-title":"Br Med J"},{"key":"477_CR12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9343(03)00231-6","volume":"114","author":"AD Tice","year":"2003","unstructured":"Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med. 2003;114:723\u20138.","journal-title":"Am J Med"},{"key":"477_CR13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dkg186","volume":"51","author":"AD Tice","year":"2003","unstructured":"Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother. 2003;51:1261\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"477_CR14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","volume":"38","author":"AD Tice","year":"2004","unstructured":"Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38:1651\u201372.","journal-title":"Clin Infect Dis"},{"key":"477_CR15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cid\/cir857","volume":"54","author":"BW Wieland","year":"2012","unstructured":"Wieland BW, Marcantoni JR, Bommarito KM, Warren DK, Marschall J. A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus. Clin Infect Dis. 2012;54:585\u201390.","journal-title":"Clin Infect Dis"},{"key":"477_CR16","unstructured":"Winters RW, Parver AK, Sansbury JD. Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy. Washington, DC: National Alliance for Infusion Therapy; 1992. p. 1\u201361."},{"key":"477_CR17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.SMJ.0000145300.28736.BB","volume":"98","author":"M Wynn","year":"2005","unstructured":"Wynn M, Dalovisio JR, Tice AD, Jiang X. Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus. South Med J. 2005;98:590\u20135.","journal-title":"South Med J"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-013-0477-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0477-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:38:06Z","timestamp":1559482686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-013-0477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,19]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0477-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,19]]}}}